Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy using phase III trial data from patients treated with a ceftaroline fosamil dosing regimen of 600 mg intravenously (i.v.) every 12 h (q12h) for 5 to 7 days for community-acquired bacterial pneumonia (CABP) were conducted. High clinical an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2013
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837912/
https://ncbi.nlm.nih.gov/pubmed/24041902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01748-13
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items